milrinone and esmolol

milrinone has been researched along with esmolol in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (7.69)	18.2507
2000's	4 (30.77)	29.6817
2010's	7 (53.85)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Alhashemi, JA; Hooper, J	1
Hauptman, PJ; Prirzker, MR; Woods, D	1
Kirby, DS; Lobato, EB; Muehlschlegel, JD; Sidi, A	2
Fujise, K; Huang, MH; McConnell, BK; Nguyen, V; Poh, KK; Rastogi, S; Tan, HC; Uretsky, BF; Wijaya, C; Wu, Y	1
Chan, KH; Chan, MY; Fujise, K; Huang, MH; Lee, CH; Low, AF; Lui, CY; Nguyen, V; Poh, KK; Sia, W; Tan, HC; Tang, LQ; Tay, EL; Xu, X	1
McNeilly, RG	1
Lennmyr, F; Martijn, C; Semenas, E; Wiklund, L; Zoerner, F	1
Lim, SY; Morishita, K; Morita, T; Nakamura, K; Ohta, H; Osuga, T; Takiguchi, M; Yokoyama, N	1
Guo, J; Nie, X; Wang, Z; Wu, Q; Yang, C	1
Chan, JYH; Hsieh, KS; Lin, IC; Lin, YJ; Lo, MH; Wu, CW; Wu, KLH	1

Reviews

1 review(s) available for milrinone and esmolol

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for milrinone and esmolol

Article	Year
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction. European journal of clinical pharmacology, 2014, Volume: 70, Issue:5 Topics: Blood Pressure; Drug Therapy, Combination; Electrocardiography; Heart Rate; Humans; Infusions, Intravenous; Milrinone; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Propanolamines	2014
Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial. Clinical drug investigation, 2015, Volume: 35, Issue:11 Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Milrinone; Propanolamines; Prospective Studies; Protective Agents; Sepsis	2015

Article

Year

Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction.

European journal of clinical pharmacology, 2014, Volume: 70, Issue:5

Topics: Blood Pressure; Drug Therapy, Combination; Electrocardiography; Heart Rate; Humans; Infusions, Intravenous; Milrinone; Myocardial Infarction; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Propanolamines

2014

Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.

Clinical drug investigation, 2015, Volume: 35, Issue:11

Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Cardiotonic Agents; Drug Therapy, Combination; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Milrinone; Propanolamines; Prospective Studies; Protective Agents; Sepsis

2015

Other Studies

10 other study(ies) available for milrinone and esmolol

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Treatment of milrinone-associated tachycardia with beta-blockers. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1998, Volume: 45, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, Epidural; Anesthesia, General; Anti-Arrhythmia Agents; Aortic Aneurysm, Abdominal; Arrhythmia, Sinus; Blood Pressure; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Elective Surgical Procedures; Ethanol; Heart Rate; Humans; Hypertension; Hypotension; Male; Metoprolol; Milrinone; Myocardial Ischemia; Propanolamines; Pulmonary Artery; Pyridones; Tachycardia	1998
Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure. Clinical cardiology, 2002, Volume: 25, Issue:5 Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Drug Therapy, Combination; Heart Failure; Humans; Infusions, Intravenous; Metoprolol; Milrinone; Propanolamines; Treatment Outcome	2002
Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. British journal of anaesthesia, 2006, Volume: 97, Issue:6 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Dobutamine; Drug Administration Schedule; Heart Rate; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Swine; Vascular Resistance; Ventricular Dysfunction, Left	2006
Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs. Acta anaesthesiologica Scandinavica, 2008, Volume: 52, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Disease Models, Animal; Heart Rate; Lactic Acid; Milrinone; Myocardial Reperfusion; Myocardial Stunning; Propanolamines; Random Allocation; Swine; Time Factors; Vascular Resistance; Ventricular Dysfunction, Left	2008
Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion. Cardiovascular drugs and therapy, 2011, Volume: 25, Issue:3 Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Apoptosis; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; In Situ Nick-End Labeling; Infusions, Intravenous; Milrinone; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Propanolamines; Rats	2011
Sepsis, venous return, and teleology. Medical hypotheses, 2014, Volume: 83, Issue:5 Topics: Algorithms; Blood Pressure; Cardiac Output; Coronary Circulation; Critical Illness; Dihydroergotamine; Dobutamine; Heart Rate; Hemodynamics; Humans; Milrinone; Models, Cardiovascular; Norepinephrine; Propanolamines; Shock, Septic; Tilt-Table Test; Vascular Resistance	2014
Milrinone and esmolol decrease cardiac damage after resuscitation from prolonged cardiac arrest. Acta anaesthesiologica Scandinavica, 2015, Volume: 59, Issue:4 Topics: Acid-Base Equilibrium; Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Cardiotonic Agents; Fluid Therapy; Heart Arrest; Heart Diseases; Male; Milrinone; Myocardium; Propanolamines; Survival Analysis; Swine; Troponin I; Vasoconstrictor Agents; Vasopressins	2015
Effects of various cardiovascular drugs on indices obtained with two-dimensional speckle tracking echocardiography of the left atrium and time-left atrial area curve analysis in healthy dogs. American journal of veterinary research, 2015, Volume: 76, Issue:8 Topics: Animals; Area Under Curve; Atrial Function, Left; Cardiovascular Agents; Dobutamine; Dogs; Echocardiography; Female; Male; Milrinone; Phenylephrine; Propanolamines	2015
Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats. Pediatric research, 2022, Volume: 92, Issue:5 Topics: Animals; Cardiotonic Agents; Catecholamines; Heart Failure; Hemodynamics; Hypertension; Male; Milrinone; Mitochondria, Heart; Norepinephrine; Rats	2022